MENU
ATHA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Athira Pharma (ATHA) Ownership - Who owns Athira Pharma?
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration... Show more
Profile
Industry
N/A
Address
18706 North Creek Parkway
Phone
+1 425 620-8501
Employees
67
Web
https://www.athira.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
15.6M
P/E Ratio
N/A
Total Cash
29.82M
Projected Growth
N/A
Total Debt
1.02M
Revenue
N/A
Risk (Beta)
2.45
Dividend Yield
N/A
Total Cash/Share
0.76
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ATHA
Capitalization
15.6M
P/E Ratio
N/A
Risk (Beta)
2.45
Dividend Yield
N/A
Total Cash
29.8M
Total Cash/Share
0.76
Total Debt
1.02M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
32M
P/B Ratio
0.49
Cash Flow
N/A
Earnings
-1.54
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
10.81
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-56.92M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-81.54
Shares Held By Institutions
5.84M
Shares Outstanding - Current
39.4M
Total Liabilities
3.56M
Total Volume MTD
N/A
Value
1
Gain YTD
-32.589
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ATHA showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
18706 North Creek Parkway
Phone
+1 425 620-8501
Employees
67
Web
https://www.athira.com